MONOCLONAL GAMMAPATHY, MULTIPLE MYELOMA AND CANCER.MOHINDRA RK; AL SARRAF M.1978; ONCOLOGY; CHE; DA. 1978; VOL. 35; NO 3; PP. 107-111; BIBL. 32 REF.Article

PHASE II FTORAFUR THERAPY IN PREVIOUSLY TREATED SQUAMOUS CELL CANCERS OF THE HEAD AND NECKCAMPBELL M; AL SARRAF M.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 4-5; PP. 713-715; BIBL. 20 REF.Article

PHASE II STUDY OF HEXAMETHYLMELAMINE FOR DISSEMINATED PROSTATIC CARCINOMADRELICHMAN A; BROWNLEE R; AL SARRAF M et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 3; PP. 309-312; BIBL. 13 REF.Article

PHASE II TRIAL OF DIANHYDROGALACTITOL IN METASTATIC MALIGNANT MELANOMA: A SOUTHWEST ONCOLOGY GROUP STUDYTHIGPEN JT; AL SARRAF M; HEWLETT JS et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 4; PP. 525-528; BIBL. 11 REF.Article

The current status of combined modality treatment containing chemotherapy in patients with esophageal cancerAL-SARRAF, M.International journal of radiation oncology, biology, physics. 1990, Vol 19, Num 3, pp 813-815, issn 0360-3016Article

CLINICAL IMMUNOLOGIC RESPONSIVENESS IN MALIGNANT DISEASE. II. IN VITRO LYMPHOCYTE RESPONSE TO PHYTOHEMAGGLUTININ AND THE EFFECT OF CYTOTOXIS DRUGS = REACTIVITE IMMUNOLOGIQUE CLINIQUE DANS LES AFFECTIONS MALIGNES. II. REPONSE IN VITRO DES LYMPHOCYTES A LA PHA ET EFFET DE MEDICAMENTS CYTOTOXIQUESAL SARRAF M; SARDESAI S; VAITKEVICIUS VK et al.1972; ONCOLOGY; SWITZ.; DA. 1972; VOL. 26; NO 4; PP. 357-368; BIBL. 3P.Serial Issue

COMBINED 5-FLUOROURACIL AND VINBLASTINE THERAPY FOR GASTROINTESTINAL AND OTHER SOLID TUMORS = TRAITEMENT DES TUMEURS GASTROINTESTINALES ET DES AUTRES TUMEURS SOLIDES PAR L'ASSOCIATION DU FLUORO-5 URACILE ET DE LA VINBLASTINEAL SARRAF M; VAUGHN CB; REED ML et al.1972; ONCOLOGY; SWITZ.; DA. 1972; VOL. 26; NO 2-3; PP. 99-113; BIBL. 3P.Serial Issue

PHASE II TRIAL WITH CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE (CAP) IN THE TREATMENT OF UROTHELIAL TRANSITIONAL CELL CARCINOMACAMPBELL M; BAKER LH; OPIPARI M et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 9-10; PP. 897-899; BIBL. 17 REF.Article

COMBINATION OF CIS-PLATINUM, ONCORIN, AND BLEOMYCIN (COB) PRIOR TO SURGERY AND/OR RADIOTHERAPY IN ADVANCED UNTREATED EPIDERMOID CANCER OF THE HEAD AND NECKPEPPARD SB; AL SARRAF M; POWERS WE et al.1980; LARYNGOSCOPE; ISSN 0023-852X; USA; DA. 1980; VOL. 90; NO 8; PART 1; PP. 1273-1280; BIBL. 24 REF.Article

Nasopharyngeal cancerALI, H; AL-SARRAF, M.Hematology/oncology clinics of North America. 1999, Vol 13, Num 4, issn 0889-8588, ix,837-847 [12 p.]Article

CARCINOMA OF PROSTATE METASTATIC TO BREASTDRELICHMAN A; AMER M; PONTES E et al.1980; UROLOGY (RIDGEWOOD); ISSN 0090-4295; USA; DA. 1980; VOL. 16; NO 3; PP. 250-255; BIBL. 35 REF.Article

COMBINED MODALITY THERAPY FOR ADVANCED HEAD AND NECK CANCERWEAVER A; LOH JJK; VANDENBERG H et al.1980; AM. J. SURG.; ISSN 0002-9610; USA; DA. 1980; VOL. 140; NO 4; PP. 549-552; BIBL. 8 REF.Article

ADJUVANT CHEMOTHERAPY WITH CIS-DIAMMINODICHLOROPLATINIUM II AND 120-HOUR INFUSION 5-FLUOROURACIL IN STAGE III AND IV SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK = CHIMIOTHERAPIE ADJUVANTE PAR LE CIS-PLATINUM ET LE 5-FLUOROURACILE EN PERFUSION DE 120 HEURES DANS LES CARCINOMES EPIDERMOIDES STADE III ET IV DE LA TETE ET DU COUDECKER DA; DRELICHMAN A; JACOBS T et al.1983; CANCER; ISSN 0008-543X; USA; DA. 1983; VOL. 51; NO 8; PP. 1353-1355; ABS. ENG; BIBL. 16 REF.Article

Evaluation of cyclophosphamide, adriamycin, and cis-platinum (CAP) in patients with disseminated prostatic carcinoma. A phase II studyDRELICHMAN, A; OLDFORD, J; AL-SARRAF, M et al.American journal of clinical oncology. 1985, Vol 8, Num 3, pp 255-259, issn 0277-3732Article

THE PRACTICALITY OF CHRONIC HEPATIC ARTERY INFUSION THERAPY OF PRIMARY AND METASTATIC HEPATIC MALIGNANCIES: TEN-YEAR RESULTS OF 124 PATIENTS IN A PROSPECTIVE PROTOCOLREED ML; VAITKEVICIUS VK; AL SARRAF M et al.1981; CANCER; ISSN 0008-543X; USA; DA. 1981; VOL. 47; NO 2; PP. 402-409; BIBL. 46 REF.Article

CISPLATIN HYDRATION WITH AND WITHOUT MANNITOL DIURESIS IN REFRACTORY DISSEMINATED MALIGNANT MELANOMA: A SOUTHWEST ONCOLOGY GROUP STUDYAL SARRAF M; FLETCHER W; OISHI N et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 1; PP. 31-35; BIBL. 18 REF.Article

STUDY OF TAMOXIFEN IN METASTATIC RENAL CELL CARCINOMA AND THE INFLUENCE OF CERTAIN PROGNOSTIC FACTORS: A SOUTHWEST ONCOLOGY GROUP STUDYAL SARRAF M; EYRE H; BONNET J et al.1981; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1981; VOL. 65; NO 5-6; PP. 447-451; BIBL. 20 REF.Article

Esophageal carcinoma advances in treatment results for locally advanced disease: reviewHERSKOVIC, A; RUSSELL, W; LIPTAY, M et al.Annals of oncology. 2012, Vol 23, Num 5, pp 1095-1103, issn 0923-7534, 9 p.Article

Chemotherapy for nasopharyngeal carcinoma: a ten-year experience = Chimiothérapie des épithéliomas rhinopharyngés: une expérience de 10 ansDECKER, D. A; DRELICHMAN, A; AL-SARRAF, M et al.Cancer. 1983, Vol 52, Num 4, pp 602-605, issn 0008-543XArticle

Osseous regeneration after therapy in patients with head and neck tumorsESTRIN, E; KELLY, J; LAZO, A et al.Cancer. 1989, Vol 64, Num 6, pp 1222-1225, issn 0008-543X, 4 p.Article

Hypercalcemia in head and neck carcinoma: incidence and prognosis = Hypercalcémie dans les tumeurs de la tête et du cou. Fréquence et pronosticWON, C; DECKER, D. A; DRELICHMAN, A et al.Cancer. 1983, Vol 52, Num 12, pp 2261-2263, issn 0008-543XArticle

Evaluation of high-dose cisplatin and 5-FU infusion as initial therapy in advanced head and neck cancerKISH, J. A; ENSLEY, J. F; JACOBS, J. R et al.American journal of clinical oncology. 1988, Vol 11, Num 5, pp 553-557, issn 0277-3732Article

Lymphoma of the frontal sinus. Case report and review of literatureBURRES, S. A; CRISSMAN, J. D; MCKENNA, J et al.Archives of otolaryngology (1960). 1984, Vol 110, Num 4, pp 270-273, issn 0003-9977Article

Solid tumor preparation for clinical application of flow cytometryENSLEY, J. F; MACIOROWSKI, Z; PIETRASZKIEWICZ, H et al.Cytometry (New York, N.Y.). 1987, Vol 8, Num 5, pp 488-493, issn 0196-4763Article

The impact of conventional morphologic analysis on response rates and survival in patients with advanced head and neck cancers treated initially with cisplatin-containing combination chemotherapyENSLEY, J; CRISSMAN, J; KISH, J et al.Cancer. 1986, Vol 57, Num 4, pp 711-717, issn 0008-543XArticle